Nisa Investment Advisors’s Integra LifeSciences IART Stock Holding History

Nisa Investment Advisors’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$301	Sell	32 -645	-95%	-$7.08K	﹤0.01%	2927
2025 Q4	$8.41K	Sell	677 -644	-49%	-$8.56K	﹤0.01%	2299
2025 Q3	$18.9K	Buy	1,321 +592	+81%	+$8.11K	﹤0.01%	2029
2025 Q2	$8.95K	Sell	729 -2,576	-78%	-$37.4K	﹤0.01%	2316
2025 Q1	$72.7K	Buy	3,305 +38	+1%	+$894	﹤0.01%	1483
2024 Q4	$74.1K	Buy	3,267 +2,800	+600%	+$61.1K	﹤0.01%	1556
2024 Q3	$8.48K	Sell	467 -12,559	-96%	-$291K	﹤0.01%	2126
2024 Q2	$380K	Sell	13,026 -11,609	-47%	-$344K	﹤0.01%	1166
2024 Q1	$873K	Sell	24,635 -18	-0.1%	-$720	0.01%	909
2023 Q4	$1.07M	Buy	24,653 +3	+0%	+$118	0.01%	829
2023 Q3	$941K	Sell	24,650 -15	-0.1%	-$631	0.01%	887
2023 Q2	$1.01M	Buy	24,665 +10	+0%	+$481	0.01%	872
2023 Q1	$1.42M	Hold	24,655	–	–	0.01%	756
2022 Q4	$1.38M	Hold	24,655	–	–	0.01%	826
2022 Q3	$1.04M	Sell	24,655 -3,745	-13%	-$192K	0.01%	799
2022 Q2	$1.53M	Buy	28,400 +3,800	+15%	+$228K	0.01%	703
2022 Q1	$1.58M	Hold	24,600	–	–	0.01%	726
2021 Q4	$1.59M	Sell	24,600 -61,424	-71%	-$4.16M	0.01%	702
2021 Q3	$5.89K	Buy	86,024 +61,424	+250%	+$4.34M	0.04%	399
2021 Q2	$1.68K	Sell	24,600 -2,200	-8%	-$156K	0.01%	767
2021 Q1	$1.85K	Sell	26,800 -67,270	-72%	-$4.56M	0.01%	739
2020 Q4	$6.11M	Buy	94,070 +67,270	+251%	+$3.62M	0.04%	389
2020 Q3	$1.26M	Hold	26,800	–	–	0.01%	736
2020 Q2	$1.26M	Hold	26,800	–	–	0.01%	709
2020 Q1	$1.2M	Buy	26,800 +2,200	+9%	+$115K	0.01%	657
2019 Q4	$1.43M	Sell	24,600 -5,610	-19%	-$334K	0.01%	759
2019 Q3	$1.81M	Buy	30,210 +5,610	+23%	+$334K	0.02%	681
2019 Q2	$1.37M	Hold	24,600	–	–	0.01%	742
2019 Q1	$1.37M	Hold	24,600	–	–	0.01%	737
2018 Q4	$1.11M	Hold	24,600	–	–	0.01%	754
2018 Q3	$1.62M	Sell	24,600 -370	-1%	-$23K	0.01%	732
2018 Q2	$1.61M	Sell	24,970 -150	-0.6%	-$9.29K	0.02%	667
2018 Q1	$1.39M	Sell	25,120 -100	-0.4%	-$5.24K	0.01%	711
2017 Q4	$1.21M	Sell	25,220 -800	-3%	-$39.2K	0.01%	766
2017 Q3	$1.31M	Hold	26,020	–	–	0.01%	734
2017 Q2	$1.42M	Buy	26,020 +1,100	+4%	+$52.5K	0.02%	697
2017 Q1	$1.05M	Sell	24,920 -280	-1%	-$12K	0.01%	801
2016 Q4	$1.08M	Hold	25,200	–	–	0.01%	799
2016 Q3	$1.04M	Hold	25,200	–	–	0.01%	781
2016 Q2	$1M	Hold	25,200	–	–	0.01%	764
2016 Q1	$849K	Buy	25,200 +12,600	+100%	+$392K	0.01%	812
2015 Q4	$427K	Hold	12,600	–	–	0.01%	1002
2015 Q3	$375K	Sell	12,600 -2,813	-18%	-$88K	0.01%	1053
2015 Q2	$424K	Hold	15,413	–	–	0.01%	1070
2015 Q1	$388K	Buy	15,413 +734	+5%	+$17.4K	0.01%	1112
2014 Q4	$325K	Hold	14,679	–	–	﹤0.01%	1129
2014 Q3	$298K	Hold	14,679	–	–	﹤0.01%	1157
2014 Q2	$282K	Sell	14,679 -2,691	-15%	-$50.1K	﹤0.01%	1195
2014 Q1	$327K	Buy	+17,370	New	+$335K	﹤0.01%	1164

Other funds holding IART

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Nisa Investment Advisors's IART Position: Q1 2026 in Review

Nisa Investment Advisors reduced its Integra LifeSciences (IART) stake by 95% in Q1 2026, selling an estimated $7.08K and leaving 32 shares worth $301. The position accounts for ﹤0.01% of the portfolio, ranked #2927.

Nisa Investment Advisors first reported a position in IART in Q1 2014 and has held it in 49 quarters since. The position peaked at $6.11M in Q4 2020. 202 funds tracked by Wall St. Rank hold IART as of Q1 2026.

Nisa Investment Advisors held 32 shares of Integra LifeSciences worth $301 as of Q1 2026.
Nisa Investment Advisors sold 645 Integra LifeSciences shares in Q1 2026, an estimated $7.08K.
Integra LifeSciences made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q1 2026, its #2927 holding.
Nisa Investment Advisors first reported a position in Integra LifeSciences in Q1 2014 and has held it in 49 quarters since.
Nisa Investment Advisors's Integra LifeSciences position peaked at $6.11M in Q4 2020.
202 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2026.

Based on Nisa Investment Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.